Posaconazole Tablet, Delayed Release
Product Images NDC 50268-683

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Posaconazole (NDC 50268-683). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avpak, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

20 (683 12)

Label for Posaconazole 100 mg delayed-release tablets, oral use, with a quantity of 20 tablets. The label shows the NDC 50268-683-12 and includes barcode information. It notes the product is Rx only and not interchangeable with Noxafil oral suspension due to formulation differences. The label states storage instructions at 20°C to 25°C and lists AvPAK as the manufacturer, located in Pulaski, TN.*

FDA Label Image

Structure (Structure)

Chemical structure of Posaconazole, the active ingredient in Posaconazole delayed-release tablets. The structure shows the detailed molecular arrangement including fluorine atoms and various ring systems characteristic of Posaconazole.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.